DE144266C
(el)
|
|
|
|
|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
US3177206A
(en)
|
1963-03-07 |
1965-04-06 |
American Home Prod |
Selective bromination of a-ring aromatic 17-ketalized steroids
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
US3673180A
(en)
|
1970-06-18 |
1972-06-27 |
Merck & Co Inc |
19-nor-6,6-ethylene-20-spiroxenes
|
US4792620A
(en)
*
|
1983-10-14 |
1988-12-20 |
Bp Chemicals Limited |
Carbonylation catalysts
|
US4739078A
(en)
|
1984-02-17 |
1988-04-19 |
The Upjohn Company |
Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
|
IE60780B1
(en)
|
1987-01-23 |
1994-08-10 |
Akzo Nv |
New 11-aryl steroid derivatives
|
DE3710728A1
(de)
|
1987-03-31 |
1988-10-13 |
Schering Ag |
Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
DE4344405C2
(de)
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
HUP0203611A3
(en)
|
1999-12-02 |
2004-07-28 |
Akzo Nobel Nv |
14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
EP1216713A1
(en)
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
EP1390040B1
(en)
|
2001-05-18 |
2007-01-03 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for use in hormone replacement therapy
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
ES2337129T3
(es)
|
2001-05-23 |
2010-04-21 |
Pantarhei Bioscience B.V. |
Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
|
EP1390042B1
(en)
|
2001-05-23 |
2007-11-28 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
DK1446128T3
(da)
|
2001-11-15 |
2007-04-02 |
Pantarhei Bioscience Bv |
Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
BR0215613A
(pt)
|
2002-02-21 |
2004-12-07 |
Schering Ag |
Composições farmacêuticas que compreendem um ou mais esteróides, um ou mais componentes tetrahidrofolato e vitamina b12
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
ES2274252T3
(es)
|
2002-06-11 |
2007-05-16 |
Pantarhei Bioscience B.V. |
Metodo de tratamiento o prevencion de desordenes de medicion inmune y formulacion farmaceutica para su uso en ellos.
|
EP1511498B1
(en)
|
2002-06-11 |
2012-11-21 |
Pantarhei Bioscience B.V. |
A method of treating human skin and a skin care composition for use in such a method
|
PT1526856E
(pt)
|
2002-07-12 |
2008-04-11 |
Pantarhei Bioscience Bv |
Composição farmacêutica que compreende derivados do estretol para ser utilizada no tratamento do cancro
|
ES2277139T3
(es)
|
2002-08-28 |
2007-07-01 |
Robert Casper |
Regimen de reposicion de estrogenos.
|
CN100528167C
(zh)
|
2002-10-23 |
2009-08-19 |
潘塔希生物科学股份有限公司 |
用于治疗癌症的包含雌四醇衍生物的药物组合物
|
EP1558265B1
(en)
|
2002-11-05 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Use of drospirenone for the treatment of hypertension
|
DE60332754D1
(de)
|
2002-11-08 |
2010-07-08 |
Pantarhei Bioscience Bv |
Synthese von oestetrol aus von oestron abgeleiteten steroiden
|
PT1624878E
(pt)
|
2003-05-22 |
2007-01-31 |
Pantarhei Bioscience Bv |
Utilização de composições que compreendem um componente estrogénico para o tratamento e prevenção da dor musculoesquelética
|
ES2933479T3
(es)
|
2003-09-29 |
2023-02-09 |
Novo Nordisk Healthcare Ag |
Estabilidad mejorada de formulaciones de progestágenos
|
DK1670440T3
(da)
|
2003-09-29 |
2014-07-07 |
Novo Nordisk As |
HRT formuleringer
|
EP1535618A1
(en)
|
2003-11-26 |
2005-06-01 |
Schering Aktiengesellschaft |
Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
|
MY151322A
(en)
|
2004-04-30 |
2014-05-15 |
Bayer Ip Gmbh |
Management of breakthrough bleeding in extended hormonal contraceptive regimens
|
EP1755562B1
(de)
|
2004-05-28 |
2013-10-09 |
Richter Gedeon Nyrt. |
Folsäurehaltiges kontrazeptivum
|
DE102004026670A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
UA89964C2
(ru)
|
2004-09-08 |
2010-03-25 |
Н.В. Органон |
15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
|
UY29527A1
(es)
|
2005-05-13 |
2006-12-29 |
Schering Ag |
Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
|
CN102796160A
(zh)
|
2005-05-26 |
2012-11-28 |
索尔瓦药物有限公司 |
17β-HSD1和STS抑制剂
|
EP1910528A2
(de)
|
2005-07-25 |
2008-04-16 |
Technische Universität Dresden |
Rna-abhängige rna-polymerase, verfahren und kits zur amplifikation und / oder markierung von rna
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
WO2007081206A1
(en)
|
2006-01-09 |
2007-07-19 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
ES2558030T3
(es)
|
2006-03-02 |
2016-02-01 |
Warner Chilcott Company, Llc |
Método anticonceptivo oral multifásico de ciclo prolongado
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
SG174785A1
(en)
|
2006-06-08 |
2011-10-28 |
Warner Chilcott Co Llc |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
MX2009000256A
(es)
|
2006-07-06 |
2009-02-18 |
Bayer Schering Pharma Ag |
Preparaciones farmaceuticas para la anticoncepcion y para prevenir el riesgo de malformaciones congenitas.
|
CN101489563A
(zh)
|
2006-07-06 |
2009-07-22 |
拜耳先灵医药股份有限公司 |
用于避孕和预防先天性畸形风险的药物制剂
|
GB0621926D0
(en)
|
2006-11-03 |
2006-12-13 |
Medlock Medical Ltd |
Multi directional stretch tubular bandages
|
CN101541326A
(zh)
|
2006-11-29 |
2009-09-23 |
惠氏公司 |
雌激素/选择性雌激素受体调节剂(serm)和雌激素/孕酮双层药片
|
BRPI0719486A2
(pt)
|
2006-12-20 |
2014-02-18 |
Duramed Pharmaceuticals Inc |
"forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente"
|
EP2114412B1
(en)
|
2007-01-08 |
2010-07-14 |
Pantarhei Bioscience B.V. |
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
|
PE20081632A1
(es)
|
2007-01-12 |
2008-12-10 |
Wyeth Corp |
Composiciones de tableta en tableta
|
US8367647B2
(en)
|
2007-06-21 |
2013-02-05 |
Pantarhei Bioscience B.V. |
Treatment of meconium aspiration syndrome with estrogens
|
ES2376793T3
(es)
|
2007-07-19 |
2012-03-16 |
Pantarhei Bioscience B.V. |
Tratamiento o prevención de trastornos hipertensivos del embarazo o retraso del crecimiento fetal
|
ES2403203T3
(es)
|
2007-08-31 |
2013-05-16 |
National University Corporation Nagoya University |
Método para producir compuesto carbonilo y prooxidante usado para la producción de compuesto carbonilo
|
EP2077272A1
(en)
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
EP2077273B1
(en)
|
2007-12-31 |
2011-09-14 |
Animal Technology Institute Taiwan |
Methods for separating casein from soluble proteins in a composition
|
US8530636B2
(en)
|
2008-05-07 |
2013-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method for regulating protein function in cells in vivo using synthetic small molecules
|
WO2010033832A2
(en)
|
2008-09-19 |
2010-03-25 |
Evestra, Inc. |
Estriol formulations
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
PE20120860A1
(es)
|
2009-06-23 |
2012-07-15 |
Bayer Ip Gmbh |
Combinacion farmaceutica que comprende levonorgestrel en combinacion con piroxicam, indometacina o diclofenaco
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
BR112012026115B1
(pt)
|
2010-04-15 |
2019-12-24 |
Bayer Ip Gmbh |
forma de dosagem oral sólida, seu uso, e unidade de acondicionamento
|
AR081670A1
(es)
|
2010-06-29 |
2012-10-10 |
Leon Farma Sa Lab |
Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
WO2012055840A1
(en)
|
2010-10-28 |
2012-05-03 |
Bayer Pharma Aktiengesellschaft |
Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
|
WO2012164095A1
(en)
|
2011-06-01 |
2012-12-06 |
Estetra S.A. |
Process for the production of estetrol intermediates
|
SG195118A1
(en)
|
2011-06-01 |
2013-12-30 |
Estetra S A |
Process for the production of estetrol intermediates
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
EP2734193B1
(en)
|
2011-07-19 |
2015-05-20 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (dhea)
|
PL2741824T3
(pl)
|
2011-08-11 |
2018-03-30 |
Estetra S.P.R.L. |
Zastosowanie estetrolu jako środka antykoncepcji awaryjnej
|
WO2013037708A1
(en)
|
2011-09-16 |
2013-03-21 |
Ferring B.V. |
A fast dissolving pharmaceutical composition
|
SG11201401282PA
(en)
|
2011-10-07 |
2014-05-29 |
Estetra Sprl |
Process for the production of estetrol
|
WO2013090117A1
(en)
|
2011-12-13 |
2013-06-20 |
Arstat, Inc. |
A multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
CA2913149A1
(en)
|
2013-05-21 |
2014-11-27 |
Predictive Therapeutics, LLC |
Therapeutic and method of use
|
WO2015040051A1
(en)
|
2013-09-18 |
2015-03-26 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
MX369035B
(es)
|
2013-12-12 |
2019-10-25 |
Donesta Bioscience B V |
Unidad de dosificacion solida de disolucion oral que contiene un componente de estetrol.
|
US9962395B2
(en)
|
2014-09-29 |
2018-05-08 |
The Regents Of The University Of California |
Compositions and methods for maintaining cognitive function
|
JP2018515552A
(ja)
|
2015-05-18 |
2018-06-14 |
アジル・セラピューティクス・インコーポレイテッドAgile Therapeutics, Inc. |
避妊用組成物ならびに有効性改善および副作用調節方法
|
PE20231714A1
(es)
|
2015-06-18 |
2023-10-23 |
Estetra Sprl |
Unidad de dosificacion orodispersable que contiene un componente estetrol
|
UA123098C2
(uk)
|
2015-06-18 |
2021-02-17 |
Естетра Спрл |
Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
|
US10894014B2
(en)
|
2015-06-18 |
2021-01-19 |
Estetra Sprl |
Orodispersible tablet containing Estetrol
|
SI3310346T1
(sl)
|
2015-06-18 |
2021-07-30 |
Estetra Sprl |
Orodisperzibilna tableta, ki vsebuje estetrol
|
AU2016282863B2
(en)
|
2015-06-23 |
2021-05-27 |
Laboratorios Leon Farma Sa |
Drospirenone-based contraceptive for a female patient affected with excess weight
|
US10863492B2
(en)
|
2015-07-16 |
2020-12-08 |
Qualcomm Incorporated |
Low latency device-to-device communication
|
WO2018065076A1
(en)
|
2016-10-28 |
2018-04-12 |
Estetra Sprl |
Method for the management of dysmenorrhea and menstrual pain
|
CA3178291A1
(en)
|
2016-08-05 |
2018-04-12 |
Estetra Srl |
Method for the management of dysmenorrhea and menstrual pain
|